Medical Need today announced that it has entered into an exclusive agreement with UK based Mitovie Ltd, relating to Mitovie´s product portfolio of special medicines. The portfolio consists of several so called “specials”, which are manufactured and provided when there are patients with special needs and there is no satisfactory treatment with a marketing authorization available, as regulated by law in UK. The manufacturing is of GDP-standard and under inspection from the British Health authority.
Medical Need holds the exclusive rights to the product portfolio in the Scandinavian countries and the two companies will cooperate around European regulatory strategies for selected products, with the ambition to not only provide them on request, on a named patient basis, but to receive a marketing authorization for these products.
About Medical Need
Medical Need is a Sweden based pharmaceutical company, focusing on the
registration, distribution, marketing and sale of orphan drugs and niche specialty
pharmaceuticals for unmet medical needs in Europe. More information on Medical
Need can be found on medicalneed.com